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Abstract: A previously unreported dihydrochromone dimer, paecilin E (1), was isolated, together
with eleven known compounds: β-sitostenone, ergosta-4,6,8 (14), 22-tetraen-3-one, cyathisterone,
byssochlamic acid, dehydromevalonic acid lactone, chevalone B, aszonalenin, dankasterone A (2),
helvolic acid, secalonic acid A and fellutanine A, from the culture filtrate extract of the marine
sponge-associated fungus Neosartorya fennelliae KUFA 0811. Nine previously reported metabolites,
including a chromanol derivative (3), (3β, 5α, 22E), 3,5-dihydroxyergosta-7,22-dien-6-one (4),
byssochlamic acid, hopan-3β,22-diol, chevalone C, sartorypyrone B, helvolic acid, lumichrome
and the alkaloid harmane were isolated from the culture of the marine-sponge associated fungus
Neosartorya tsunodae KUFC 9213. Paecilin E (1), dankasterone A (2), a chromanol derivative (3),
(3β, 5α, 22E)-3,5-dihydroxyergosta-7,22-dien-6-one (4), hopan-3β,22-diol (5), lumichrome (6), and
harmane (7) were tested for their antibacterial activity against Gram-positive and Gram-negative
reference and multidrug-resistant strains isolated from the environment. While paecilin E (1) was
active against S. aureus ATCC 29213 and E. faecalis ATCC 29212, dankastetrone A (2) was only effective
against E. faecalis ATCC 29212 and the multidrug-resistant VRE E. faecalis A5/102. Both compounds
neither inhibit biofilm mass production in any of the strains at the concentrations tested nor exhibit
synergistic association with antibiotics.
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1. Introduction
In the past decade, marine-derived fungi have increasingly become an important source of
bioactive marine natural products, since many consider them among the world’s greatest resources for
unprecedented biodiversity and chemodiversity. Moreover, with established methods of cultivation,
they can produce quantity of compounds with potential for medicinal chemistry development,
clinical trials and marketing [1]. The fungi belonging to the genus Neosartorya (Trichocomaceae)
have been revealed to be an important source of interesting bioactive metabolites such as polyketides,
isocoumarins, ergosterol analogs, meroditerpenes, pyripyropenes, benzoic acid derivatives, prenylated
indole derivatives, tryptoquivalines, fiscalins, phenylalanine-derived alkaloids and cyclopeptides [2].
Marine-derived fungi are also known to produce a myriad of structurally unique metabolites not
produced by their terrestrial counterparts [3]. Our group has recently isolated and identified
meroditerpene analogs and the indole alkaloids, from some marine-derived fungi from the genus
Neosartorya, with interesting antibacterial activity against Gram-positive bacteria (S. aureus and
B. subtillis) and multidrug-resistant isolates from the environment (MRSA and VRE). Some of these
compounds also had synergistic effects with antibiotics to which the bacteria are resistant. Some of
these compounds also inhibit biofilm formation at MIC [4].
In our ongoing search for new natural antibiotics from marine-derived fungi, we have investigated
secondary metabolites from the culture of Neosartorya fennelliae KUFA 0811, isolated from the marine
sponge Clathria reinwardtii, collected from Samaesan Island in the Gulf of Thailand. Previously, we only
isolated two compounds from the marine sponge-associated N. tsunodae KUFC 9213 [5], therefore we
have cultured this fungus to reexamine its secondary metabolites.
Chromatographic fractionation and further purification of the ethyl acetate extract of N. fennelliae
KUFA 0811, yielded a previously undescribed 2,3-dihydro-4H-chromen-4-one dimer which we have
named paecilin E (1), in addition to the previously described dehydromevalonic acid lactone [6],
byssochlamic acid [7], β-sitostenone [8], ergosta-4,6,8 (14), 22-tetraen-3-one [9], cyathisterone [10],
dankasterone A (2) [11], chevalone B [12], helvolic acid [5], aszonalenin [13], secalonic acid A [14]
and fellutanine A [13]. The ethyl acetate extract of N. tsunodae KUFC 9213 furnished, besides
sartorypyrone B and helvolic acid which were previous isolated in our first study [5], byssochlamic
acid [7], hopan-3β,22-diol (5) [15], chevalone C [16], a chromanol derivative (3) [17,18], (3β,5α,22E)-
3,5-dihydroxyergosta-7,22-dien-6-one (4) [19], the alkaloid harmane (7) [20], and lumichrome (6) [21].
Paecilin E (1), dankasterone A (2), a chromanol derivative (3), (3β,5α,22E)-3,5-dihydroxyergosta-
7,22-dien-6-one (4), hopan-3β,22-diol (5), lumichrome (6) and harmane (7), (Figure 1) were tested for
their growth inhibitory activity against two Gram-positive (Staphylococcus aureus ATCC 29213 and
Enterococcus faecalis ATCC 29212), two Gram-negative (Escherichia coli ATCC 25922 and Pseudomonas
aeruginosa ATCC 27853) bacteria, a clinical isolate sensitive to the most commonly used antibiotic
families, and four multidrug-resistant isolates from the environment. Paecilin E (1) and dankasterone
A (2) were also investigated for their capacity to inhibit biofilm formation in the four reference strains.
The potential synergism between these two compounds and the clinically used antibiotics was also
investigated against multidrug-resistant isolates from the environment.
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Figure 1. Structures of paecilin E (1) and dankasterone A (2), a chromanol derivative (3), (3β,5α,22E),
3,5-dihydroxyergosta-7,22-dien-6-one (4), hopan-3β,22-diol (5), lumichrome (6), harmane (7).
2. Results and Discussion
The structures of byssochlamic acid [7], hopan-3β,22-diol (5) [15], chevalone B [12], chevalone
C [16], sartorypyrone B [5], helvolic acid [5], lumichrome (6) [21], harmane (7) [20], β-sitostenone [8],
ergosta-4,6,8 [14] 22-tetraen-3-one [19], cyathisterone [10], dehydromevalonic acid lactone [6],
aszonalenin [13], secalonic acid A [14] and fellutanine A [13] (Figure 1 and Supplementary Materials,
Figure S1) were elucidated by analysis of their 1H, 13C NMR spectra and HRMS data, as well as
by comparison of their spectral data to those reported in the literature (Supplementary Materials,
Figures S2–S31).
The molecular formula of 1, a white crystal (mp 203–205 ◦C), was established as C32H30O14 on the
basis of its (+)-HRESIMS m/z 639.1718 [M + H]+, (calculated 639.1712 for C32H31O14), which indicated
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eighteen degrees of unsaturation. The IR spectrum showed absorption bands for hydroxyl (3443 cm−1),
conjugated ketone carbonyl (1645 cm−1), ester carbonyl (1790 cm−1), lactone carbonyl (1738 cm−1), and
aromatic (1470 cm−1) groups. The 13C NMR spectrum (Table 1, Supplementary Materials, Figure S33)
displayed thirty two carbon signals which, based on DEPT and HSQC spectrum (Supplementary
Materials, Figure S35), can be classified as two conjugated ketone carbonyl (δC 195.3 and 194.9),
four ester carbonyl (δC 175.5, 174.9, 169.3 and 168.9), eight quaternary sp2 (δC 160.4, 158.2, 158.1, 156.1,
116.6, 114.8, 107.5 and 107.0), four methine sp2 (δC 140.9, 140.6, 109.2 and 107.4), two oxyquaternary sp3
(δC 85.4 and 83.9), two oxymethine sp3 (δC 81.9 and 81.7), two methoxyl (δC 53.3 and 53.3), two methine
sp3 (δC 32.9 and 32.5), four methylene sp3 (δC 39.2, 39,2, 36.9, 35.3) and two methyl (δC 14.6 and 14.1)
groups. Based on the type and values of their chemical shifts, these carbons were suspected to arise
from two structurally similar moieties within compound 1.
Table 1. 1H and 13C Nuclear magnetic resonance (NMR) (DMSO, 500 and 125 MHz) and Heteronuclear
Multiple Bond Correlation (HMBC) assignment for 1.
Position δC, Type δH, (J in Hz) COSY HMBC
2 85.4, C -
3α 32.9, CH2 3.58, d (17.4) H-3β C-2, 4, 9, 10
β 3.05, d (17.4) H-3α C-4, 4a
4 194.9, CO -
5 107.5, C -
6 109.2, CH 6.61, d (8.6) H-7 C-4a, 8
7 140.9, CH 7.50, d (8.6) H-6 C-5, 8a
8 114.6, C -
9 168.9, CO (Ac) -
OMe-9 53.3, CH3 3.70, s C-9
10 81.7, CH 4.85, d (7.3) H-11 C-2, 3, 12, 13, 14
11 32.9, CH 2.85, m H-10, H2-12, Me-14 C-2, 13, 14
12α 35.3, CH2 1.75, dd (17.0, 9.9) H-11, 12β C-10, 13, 14
β 2.41, dd (17.0, 8.4) H-11, 12 α C-10, 13, 14
13 174.9, CO -
14 14.1, CH3 1.06, d (7.1) H-11 C-10, 11, 12
2′ 83.9, C -
3′α 39.2, CH2 3.57, d (17.4) H-3′β C-2′, 4′, 9′, 10′
β 3.09, d (17.4) H-3′α C-4′, 4′a
4′ 195.3, CO -
4′a 107.0, C -
5′ 158.1, C -
6′ 116.6, C -
7′ 140.6, CH 7.61, d (8.6) H-8′ C-5′, 8′a, 8
8′ 107.4, CH 6.60, d (8.6) H-7′ C-6′, 8′a
8′a 158.2, C -
9′ 169.3, CO (Ac) -
OMe-9′ 53.3, CH3 3.69, s C-9′
10′ 81.9, CH 4.97, d (6.7) H-11′ C-3′, 11′, 13′, 14′
11′ 32.5, CH 2.97, m H-10
′, 11′, 12′a,
12′β C-2
′, 13′, 14′
12′α 36.9, CH2 2.33, dd (17.0, 5.4) H-11′, 12′β C-10′, 13′, 14′
β 2.86, dd (17.0, 8.1) H-11′, 12′α C-10′, 13′, 14′
13′ 175.5, CO -
14′ 14.6, CH3 1.17, d (7.1) H-11′ C-10′, 11′, 12′
OH-5 - 11.56, s C-4a, 5, 6
OH-5′ - 11.83, s C-4′a, 5′, 6′
The 1H NMR and COSY spectra (Table 1, Supplementary Materials, Figures S32 and S34) exhibited
two singlets of the hydrogen-bonded phenolic hydroxyl groups at δH 11.56 and 11.83, two pairs of
ortho-coupled aromatic protons at δH 7.50, d (J = 8.6 Hz)/6.61, d (J = 8.6 Hz) and 7.61, d (J = 8.6 Hz)/6.60,
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d (J = 8.6 Hz), a pair of doublets at δH 4.85, d (J = 7.3 Hz) and δH 4.97, d (J = 6.7 Hz), two pairs of
mutually coupled methylene protons at δH 3.58, d (J = 17.4 Hz)/3.05, d (J = 17.4 Hz); δH 3.57, d
(J = 17.4 Hz)/3.09, d (J = 17.4 Hz) and δH 2.41, dd (J = 17.0, 8.4 Hz)/1.75 dd (J = 17.0, 9.9 Hz); δH 2.86,
dd (J = 17.0, 8.1 Hz)/2.33, dd (J = 17.0, 5.4 Hz), two methyl singlets at δH 1.06, d (J = 7.1 Hz) and
δH 1.17, d (J = 7.1 Hz) and two methoxyl singlets at δH 3.70 and 3.69.
The existence of a 2,2,8-trisubstituted 5-hydroxy-2,3-dihydro-4H-chromen-4-one moiety was
substantiated by COSY correlations from H-6 (δH 6.61, d, J = 8.6 Hz; δC 109.2) to H-7 (δH 7.50, d,
J = 8.6 Hz; δC 140.9), and HMBC correlations (Supplementary Materials, Figure S36) from H-6 to C-4a
(δC 107.5) and C-8 (δC 114.6), H-7 to C-5 (δC 160.4) and C-8a (δC 156.1), OH-5 (δH 11.56, s) to C-4a, C-5,
C-6 (δC 109.2), H-3α (δH 3.58, d, J = 17.4 Hz; δC 39.2) to C-2 (δC 85.4) and C-4 (δC 194.9), H-3β (δH 3.05,
d, J = 17.4 Hz; δC 39.2) to C-4 and C-4a. One of the substituents on C-2 was deduced as a methyl
formate since both H-3α and the methoxyl singlet (δH 3.70) exhibited HMBC cross peaks to the ester
carbonyl at δC 168.9 (C-9). Another substituent was 4-methyldihydrofuran-2-(3H)-one, which linked
through C-10, was substantiated by COSY correlations from H-10 (δH 4.85, d, J = 7.3 Hz)/H-11 (δH 2.85,
m)/H2-12 (δH 1.75, dd, J = 17.0, 9.9 Hz and 2.41, dd, J = 17.0, 8.4 Hz), and from H-11 to Me-14 (δH 1.06,
d, J = 7.1 Hz) as well as by HMBC correlations from H-10 to C-3, C-11 (δC 32.9), C-12 (δC 35.3) and C-13
(δC 174.9), H2-12 to C-10 (δC 81.7), C-13, and Me-14 (δC 14.1) as well as from H-3α to C-10. However,
this first monomer constituted only half of the molecular formula, i.e., C16H15O7 and still lacked the
substituent on C-8.
The second monomer also consisted of a 5-hydroxy-2,3-dihydro-4H-chromen-4-one core, but it
was 2,2,6-trisubstituted as can be corroborated by COSY correlations from H-7′ (δH 7.61, d, J = 8.6 Hz;
δC 140.6) to H-8′ (δH 6.60, d, J = 8.6 Hz; δC 107.4) as well as by HMBC correlations from H-7′ to C-5′
(δC 158.1), C-8′a (δC 158.2), H-8′ to C-6′ (δC 116.6) and C-4′a (δC 107.0), OH-5′ (δH 11.83, s) to C-5′, C-4′a
and C-6′, H-3′β (δH 3.09, d, J = 17.4 Hz, δC 39.2) to C-4′ (δC195.3) and C-4′a, and H-3′α (δH 3.57, dd,
J = 17.4 Hz; δC 39.2) to C-4′ and C-2′(δC 83.9). Similarly, the substituents on C-2′ were methyl formate
and 4-methyldihydrofuran-2-(3H)-one, through C-10′, which were based on HMBC correlations from
H-3′α to C-9′ (δC 169.3), C-10′ (δC 81.9), H-10′ (δH 4.97, d, J = 6.4 Hz) to C-2′, C-3′, C-11′ (δC 32.5), C-13′
(δC 175.5) and Me-14′ (δC 14.6) as well as the coupling system, as observed in the COSY spectrum,
from H-10′, through H-11′ (δH 2.97, m) and H2-12′ (δH 2.33, dd, J = 17.0, 5.4 Hz and 2.86, dd, J = 17.0,
8.1 Hz), and from H-11′ to Me-14′. Like the first monomer, the second monomer also had C16H15O7,
and still also lacked the substituent on C-6′. That the two monomers were connected through C-8 and
C-6′ was supported by HMBC correlations from H-7 to C-6′ as well as from H-7′ to C-8.
A literature search revealed that both monomers and dimers of 5-hydroxy-2,3-dihydro-4H-
chromen-4-one with the methyl formate and γ-lactone substituents on C-2 have been previously
reported. Guo et al. [22] reported the isolation of a 8-8′ dimer (paecilin A) and its monomer (paecilin B)
of 5-hydroxy-2,3-dihydro-4H-chromen-4-one with the methyl formate and γ-lactone substituents on
C-2 from the crude extract of mycelium of the endophytic fungus Paeciliomyces sp. (tree 1–7), which
was isolated from mangrove bark from Xiamen, China. However, the authors did not determine the
stereochemistry of both compounds. Bao et al. [23] reported the isolation, among others, of another
8-8′dimer whose 1H and 13C NMR chemical shift values of the 4-methyldihydrofuran-2-(3H)-one
moiety were slightly different from those of paecilin A. Through the NOESY correlations, they
postulated that the compound might be an epimer of paecilin A, and thus named it paecilin C.
However, only the relative configurations of the stereogenic carbons of the methyl γ-lactone rings
were established. El-Elimat et al. [24] mentioned the isolation of paecilin D using a bioactivity-guided
fractionation of the organic extract of an unidentified fungus (MSX 45109). However, the structure
of paecilin D was published later with the name 11-deoxyblennolide D [25], another monomer of
5-hydroxy-2,3-dihydro-4H-chromen-4-one with the methyl formate and γ-lactone substituents on C-2.
Since 1 was obtained as a suitable crystal, its X-ray analysis was carried out. The ORTEP
view, shown in Figure 2, not only confirmed the proposed structure of 1 as a 6-8 dimer of
5-hydroxy-2,3-dihydro-4H-chromen-4-one with the methyl formate and γ-lactone substituents on C-2,
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but also determined unequivocally the absolute configurations of C-2, C-2′, C-10, C-10′, C-11, C-11′
as 2R, 2′R, 10S, 10′S, 11R and 11′R. Literature search revealed that 1 has never been previously
reported and therefore named paecilin E. It is worth mentioning that this is the first dimer of
5-hydroxy-2,3-dihydro-4H-chromen-4-one with the methyl formate and γ-lactone substituents on
C-2 with complete assignment of the absolute configurations of the stereogenic carbons of both
2,3-dihydropyrone and hydroxyl-γ-lactone rings.
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Analysis of the (+)-HRESIMS, 1H, 13C NMR, COSY, HSQC and HMBC and X-ray crystallographic
data of compound 2 (Supplementary Materials, Table S2, Figures S37–S40 and S49) revealed that
it was dankasterone A. This compound was first reported as dankasterone, a cytotoxic steroid,
isolated from a marine-derived fungus Gymnascella dankaliensis (Castellani) Currah OUPS-N 134,
by Amagata et al. [26]. However, the stereochemistry of C-24 was incorrectly assigned. Later on,
Amagata and coworkers [11] published the structure of dankasterone, together with other analogs, but
inverted the stereochemistry of C-24 and renamed it dankasterone A.
Analysis of the 1H, 13C NMR, COSY, HSQC, HMBC, NOESY (Table 2, Supplementary Materials,
Figures S41–S46) and (+)-HRESIMS data of 3, revealed that it has the same planar structure as that
of one of the highly substituted chromanols, isolated from cultures of Aspergillus duricaulis [17].
However, there were no details of the 1H and 13C NMR data of the isolated compounds. The authors
have proposed that the compound was a mixture of two diastereoisomers, differing in the absolute
configurations at C-1, due to a ring-chain tautomerism of the hydroxyphthalide. Moreover, the authors
have found that this compound did not show any optical rotation or a Cotton effect [17] and there was
no indication of the determination of the absolute configurations of any stereogenic carbons of the
isolated chromanol derivatives.
Later on, the same group [18] described the same compound as colorless oil which contained
a mixture of the epimers and reported two sets of 1H and 13C NMR data (in deuterated acetone)
for both epimers in the mixture but without assignment of the stereochemistry of C-1. On the
contrary, compound 3 is optically active (levorotatory), with [[α]25D −80 (c 0.05, CHCl3), and exhibited
only one set of the 1H and 13C NMR data (Table 2). Therefore, we concluded that 3 was a pure
compound and not a mixture of the epimers as described by Archenbach et al. [17,18]. This
prompted us to investigate the absolute configurations of the stereogenic carbons in 3. Since 3
could be obtained in a suitable crystal (mp 223–224 ◦C), its X-ray analysis was carried out and
the ORTEP view is shown in Figure 3. Therefore, 3 was identified as (1R, 8S, 9R)-1,9-dihydroxy-8-
(2-hydroxypropan-2-yl)-4-methoxy-5-methyl-1,7,8,9-tetrahydro-3H-furo[3,4-f]chromen-3-one.
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Table 2. 1H and 13C NMR (CDCl3, 300 MHz and 75 MHz) and HMBC assignment for 3.
Position δC, Type δH, (J in Hz) COSY HMBC NOESY
1 95.6, CH 6.64, s - C-3 OH-1, H-9
3 166.1, CO -
3a 109.4, C -
4 155.9, C -
5 120.0, C -
5a 158.4, C
7α 63.9, CH2 4.29, dd (12.0, 10.6) H-7β, 8 C-5a, 8, 9 H-7β
β 4.53, dd (11.6, 2.4) H-7α C-5a, 8, 9
8 46.6, CH 1.79, dt (11.9, 2.8) H-7α C-2′, 7 H-8, Me-1′, 3′
9 57.8, CH 5.16, br -
9a 146.8, C -
9b 117.4, C -
10 8.6, CH3 2.05, s - C-3a, 4, 5, 5a, 9a OMe-4
1′ 28.4, CH3 1.27, s - C-2′, 3′, 8 H-8, OH-2′, Me-3′
2′ 69.9, C -
3′ 27.7, CH3 1.24, s C-1′, 2′, 8 H-8, OH-2′, Me-1′
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[α]20D −4.37 (EtOH, 0.01), which is opposite to that of 4, i.e., [α]20D +60 (CHCl3, 0.05).  
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Analysis of the (+)-HRESIMS, 1H, 13C NMR, COSY, HSQC and HMBC data of 4 revealed that
it was (3β,22E)-3,5-dihydroxyergosta-7,22-dien-6-one (Supplementary Materials, Table S2, Figures
S47 and S48). However, from a survey of the literature, the stereochemistry of C-5 remained elusive.
Aiello et al. [27] first described the isolation of 24-methylcholesta-7,22E-dien-3β,5α-diol-6-one and
suggested that, due to the low field chemical shift of H-3 (δH 4.03, m), the hydroxyl group on
C-5 was in the α position. However, no optical rotation of this compound was reported. Later on,
Ishizuka et al. [28] reported the isolation of 3β,5α-dihydroxy (22E, 24R)-ergosta-7,22-dien-6-one from
the fruit bodies of an edible mushroom Grifola frondosa (Fr.) S.F. Gray (Polyporaceae). Interestingly, the
optical rotation of this compound was reported as dextrorotatory, [α]25D +9.1 (CHCl3, 0.1). Finally, the
authors confirmed the structure of this compound by chemical transformation of ergosterol acetate by
treatment with Na2Cr2O7, followed by deprotection of 3-acetoxy group. Recently, Fangkratok et al. [19]
reported the isolation of (3β,5α22E)-3,5-dihydroxyergosta-7,22-dien-6-one from the extract of the
mycelia of Lentinus polychrous, a Thai local edible mushroom. The 1H and 13C NMR data of this
compound were very similar to those of 4 except for the chemical shift value of C-10. Furthermore, the
sign of the optical rotation reported by Fangkratok et al. was levorotatory, [α]20D −4.37 (EtOH, 0.01),
which is opposite to that of 4, i.e., [α]20D +60 (CHCl3, 0.05).
In order to clarify the controversy and to determine unequivocally the position of the hydroxyl
group on C-5 of 4, the absolute configuration of C-5 was determined by comparison of the experimental
electronic circular dichroism (ECD) spectrum with the calculated ECD spectra. Conformational
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analysis of the C-5S and C-5R diastereoisomers of 4 by molecular mechanics (MMFF95 force field)
resulted in similar lowest energy conformations for both compounds, with rings A and C with chair
conformation (Figure 4).
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(3β,5α,22E)-3,5-dihydroxyergosta-7,22-dien-6-one (4), hopan-3β,22-diol (5), lumichrome (6) and 
harmane (7) (Figure 1) were tested for their antibacterial activity against Gram-positive and Gram-
negative bacteria, including four reference strains, a clinical isolate sensitive to the most commonly 
used antibiotic families, and four multidrug-resistant isolates from the environment. In the range of 
concentrations tested, none of the compounds were active against Gram-negative bacteria. Paecilin E 
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However, both model’s conformational energies were further minimized by a DFT (density
functional theory) method starting with ring A in chair conformation and also in boat conformation.
This was considered necessary because rings A and B house the main low energy UV and ECD
chromophore groups, which may engage in intramolecular hydrogen bonds, depending on the
particular conformation of ring A. The DFT minimization showed that the amount of energy released
by the formation of intramolecular hydrogen bonds is not enough to stabilize the boat conformations.
The chair conformations are more stable than its boat counterparts in excess of 2 kcal/mol (Gibbs
energy in methanol), making it overwhelmingly predominant. As such, ECD spectra were calculated
for the A-chair C-5S and C-5R diastereoisomers of 4, using a TD-DFT method. Figure 5 compares these
spectra and shows how the calculated spectrum for the C-5R isomer fits the experimental data much
better, providing enough evidence to conclude that compound 4 is the C-5R diastereoisomer, rather
than the C-5S.
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Paecilin E (1), dankasterone A (2), a chromanol derivative (3), (3β,5α,22E)-3,5-dihydroxyergosta-
7,22-dien-6-one (4), h pan-3β,22-diol (5), lumichrome (6) and harmane (7) (Fig re 1) wer tested
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reference strains, a clinical isolate sensitive to the most commonly used antibiotic families, and four
multidrug-resistant isolates from the environment. In the range of concentrations tested, none of the
compounds were active against Gram-negative bacteria. Paecilin E (1) exhibited an inhibitory effect on
both Staphylococcus aureus ATCC 29213 and Enterococcus faecalis ATCC 29212 (Table 3), with MIC values
of 32 µg/mL and 16 µg/mL, respectively. However, when tested in a vancomycin-resistant (VRE)
strain that was sensitive to ampicillin (E. faecalis A5/102), the MIC obtained was higher than that of
the reference strain (64 µg/mL as opposed to 16 µg/mL). In the range of concentration tested, paecilin
E (1) was ineffective against a VRE strain which was also resistant to ampicillin (E. faecalis B3/101).
In the case of S. aureus strains isolated from the environment, paecilin E (1) was incapable of inhibiting
the growth of the bacterial strain sensitive to the most commonly used antibiotic families (S. aureus
40/61/24) as well as of MRSA S. aureus 66/1. However, dankasterone A (2) was only effective against
E. faecalis ATCC 29212 and VRE E. faecalis A5/102, with MIC of 32 µg/mL and 64 µg/mL, respectively.
Table 3. Antibacterial activity of paecilin E (1) and dankasterone A (2). MIC and MBC are expressed
in µg/mL.
Paecilin E (1) Dankasterone A (2)
Bacterial strain MIC MBC MIC MBC
E.coli ATCC 25922 >64 >64 >64 >64
E.coli SA/2 (ESBL) >64 >64 >64 >64
P. aeruginosa ATCC 27853 >64 >64 >64 >64
E. faecalis ATCC29212 16 >64 32 >64
E. faecalis A5/102 (VRE) 64 >64 64 >64
E. faecalis B3/101 (VRE) >64 >64 >64 >64
S. aureus ATCC 29213 32 >64 >64 >64
S. aureus 40/61/24 >64 >64 >64 >64
S. aureus 66/1 (MRSA) >64 >64 >64 >64
MIC = mininmum inhibitory concentration; MBC = minimum batericidal concentration.
The effect of paecilin E (1) and dankasterone A (2) on biofilm formation was also assessed in four
reference strains and neither of them revealed an inhibitory effect on biomass production in any of the
strains at the concentration tested. Regarding the screening for potential synergies between the test
compounds and clinical relevant antibiotics, none of the compounds revealed a synergistic association
with antibiotics, as determined by the different methodologies used.
3. Experimental Section
3.1. General Experimental Procedures
Melting points were determined on a Bock monoscope and are uncorrected. Optical rotations
were measured on an ADP410 Polarimeter (Bellingham + Stanley Ltd., Tunbridge Wells, Kent, UK).
Infrared spectra were recorded in a KBr microplate in a FTIR spectrometer Nicolet iS10 from Thermo
Scientific (Waltham, MA, USA) with Smart OMNI-Transmission accessory (Software 188 OMNIC 8.3).
1H and 13C NMR spectra were recorded at ambient temperature on a Bruker AMC instrument
(Bruker Biosciences Corporation, Billerica, MA, USA) operating at 300 or 500 and 75 or 125 MHz,
respectively. High resolution mass spectra were measured with a Waters Xevo QToF mass spectrometer
(Waters Corporations, Milford, MA, USA) coupled to a Waters Aquity UPLC system. A Merck
(Darmstadt, Germany) silica gel GF254 was used for preparative TLC, and a Merck Si gel 60 (0.2–0.5 mm)
was used for column chromatography.
3.2. Fungal Material
The fungal strains, KUFC 9213 and KUFA 0811, were isolated from the marine sponges
Aka coralliphaga, collected at the coral reef of Similan Islands, Phang Nga Provice (altitude 8◦39′5.39” N
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97◦38′16.19” E), in April 2010 and Clathria reinwardtii, collected from Samaesan Island, Amphur
Sattahip, Chonburi Province, Thailand (altitude 12◦34′30.61” N 100◦57′5.56” E) in February 2015,
respectively. The sponge samples were washed with 0.06% sodium hypochlorite solution for 1 min,
followed by sterilized seawater three times and dried on sterile filter papers under aseptic conditions.
The sponges were cut into small pieces (5 × 5 mm) and placed on Petri dish plates containing
15 mL malt extract agar (MEA) medium containing 70% seawater, and incubated at 28 ◦C for
5–7 days. Hyphal tips emerged from sponge pieces were individually transferred onto MEA slant for
further identification.
The fungi were identified to species level, based on morphological characteristics such as colony
growth rate and growth pattern on standard media, namely Czapek’s agar (CZA), Czapek yeast
autolysate agar (CYA), MEA and microscopic characteristics including size, shape, ornamentation
of ascospores under light and scanning electron microscopes. The fungi were further identified
by molecular techniques using ITS primers. DNA was extracted from young mycelia following
a modified Murray and Thompson method [29]. Primer pairs ITS1 and ITS4 [30] were used for
ITS gene amplification. PCR reactions were conducted on Thermal Cycler and the amplification
process consisted of initial denaturation at 95 ◦C for 5 min, 34 cycles at 95 ◦C for 1 min (denaturation),
at 55 ◦C for 1 min (annealing) and at 72 ◦C for 1.5 min (extension), followed by final extension at
72 ◦C for 10 min. PCR products were examined by Agarose gel electrophoresis (1% agarose with
1× TBE buffer) and visualized under UV light after staining with ethidium bromide. DNA sequencing
analyses were sequenced using dideoxyribonucleotide chain termination method [31] by Macrogen
Inc. (Seoul, Korea).
The DNA sequences were edited using FinchTV software and submitted into BLAST program for
alignment and compared with that of fungal species in the NCBI database (http://www.ncbi.nlm.nih.
gov/). The strain KUFC 9213 and KUFA 0811 were identified as Neosartorya tsunodae Yaguchi, Abliz
and Y. Horie and N. fennelliae Kwon-Chung and S.J. Kim, respectively, and their ITS gene sequences
were deposited in GenBank with accession numbers KT201524 for KUFC 9213 and KU955859 for KUFA
0811. The pure cultures were maintained at Department of Plant Pathology, Faculty of Agriculture,
Kasetsart University, Bangkok, Thailand.
3.3. Extraction and Isolation
Each fungus was cultured for one week at 28 ◦C in separate Petri dish plates containing 20 mL of
potato dextrose agar medium per dish. Five mycelium plugs (5 mm in diam.) of each fungus were
transferred into separate 500 mL Erlenmeyer flasks containing 200 mL of potato dextrose broth and
incubated on a rotary shaker at 120 rpm for one week at 28 ◦C to prepare mycelial suspension. Fifty
1000 mL Erlenmeyer flasks (for each fungus), each containing 300 g of cooked rice, were autoclaved at
121 ◦C for 15 min, and when they were cooled to room temperature, 20 mL of mycelial suspension of
a fungus were inoculated per flask, and incubated at 28 ◦C for 30 days. Then, 500 mL of ethyl acetate
was added to each moldy flask and macerated for 7 days and then filtered with Whatman No. 1 filter
paper. The organic solutions were combined and evaporated under reduced pressure to furnish the
crude ethyl acetate extracts of N. tsunodae KUFC 9213 (105 g) and N. fennelliae KUFA 0811 (135 g).
The crude ethyl acetate of N. fennelliae KUFA 0811 (135 g) was washed with H2O and extracted with
CHCl3 in the same manner. The crude chloroform extract (85 g) was applied on a column of silica gel
(420 g), and eluted with mixtures of petrol-CHCl3, CHCl3-Me2CO and CHCl3-MeOH, wherein 250 mL
fractions were collected as follows: Frs 1–30 (petrol-CHCl3, 1:1), 31–86 (petrol-CHCl3, 3:7), 87–202
(petrol-CHCl3, 1:9), 203–436 (CHCl3), 437–579 (CHCl3-Me2CO, 9:1), 580–690 (CHCl3-Me2CO, 7:3). Frs
31–60 were combined (6.12 g) and purified by TLC (Silica gel G254, Petrol-CHCl3-EtOAc-HCO2H,
1:8:1:0.01) to give 16.4 mg of β-sitostenone [8] and 10.5 mg of ergosta-4,6,8 (14), 22-tetraen-3-one [9].
Frs 106–135 were combined (254 g) and purified by TLC (Silica gel G254, Petrol-CHCl3-Petrol-HCO2H,
9:1:0.01) to give 93 mg of yellow viscous liquid which was applied on a Sephadex LH-20 column
(10 g) and eluted with MeOH and a 1:1 mixture of MeOH:CH2Cl2 wherein 1 mL 30 sfrs were collected.
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Sfrs 16–30 were combined and crystallized in a mixture of CHCl3 and MeOH to give 12.5 mg of
dehydromevalonic acid lactone [6]. Frs 211–255 were combined (201 mg) and crystalized in a mixture
of CHCl3 and petrol to give 12.3 mg of byssochlamic acid. The mother liquor was combined with the
combined frs 136–165 (546 mg) and the combined frs 226–255 (700 mg), and applied on a a column
of silica gel (35 g), and eluted with mixtures of petrol-CHCl3, wherein 250 mL sfrs were collected
as follows: Sfrs 1–77 (petrol-CHCl3, 1:1), 78–142 (petrol-CHCl3, 3:7), 143–220 (petrol-CHCl3, 1:9),
221–255 (CHCl3). Sfrs 51–63 were combined (50 mg) and crystalized in a mixture of CHCl3 and
petrol to give 26 mg of byssochlamic acid. Sfrs 125–220 were combined (160 mg) and crystalized
in a mixture of CHCl3 and petrol to give 120 mg of cyathisterone [10]. Frs 361–420 were combined
(312 mg) and purified by TLC (Silica gel G254, petrol-CHCl3-EtOAc-HCO2H, 1:8:1:0.01) to give 9 mg
of byssochlamic acid and 20.3 mg of dankasterone A (2) [11]. The combined frs 256–360 (1.33 g) and
421–443 (4.9 g) were joined together and applied on a column of silica gel (65 g), and eluted with
mixtures of petrol-CHCl3 and CHCl3-Me2CO, wherein 250 mL sfrs were collected as follows: Sfrs
1–250 (petrol-CHCl3, 1:1), 251–386 (petrol-CHCl3, 3:7), 387–605 (petrol-CHCl3, 1:9), 606–858 (CHCl3),
859–915 (CHCl3-Me2CO, 9:1). Sfrs 316–365 were combined (35 mg) and purified by TLC (Silica
gel G254, petrol-CHCl3-EtOAc-HCO2H, 1:8:1:0.01) to give 10.5 mg of chevalone B [12] and 4 mg of
dankasterone A (2). Sfrs 418–480 were combined (11.3 mg) and crystallized in MeOH to give 7 mg of
aszonalenin [13] Fr 449 (736 mg) was crystallized in MeOH to give 138 mg of secalonic acid A [14].
Frs 450–452 were combined (1.7 g) and applied on a column of silica gel (100 g), and eluted with
mixtures of petrol-CHCl3 andCHCl3-Me2CO, wherein 250 mL sfrs were collected as follows: Sfrs 1–23
(petrol-CHCl3, 1:1), 24–58 (petrol-CHCl3, 3:7), 59–150 (petrol-CHCl3, 1:9), 151–594 (CHCl3), 595–649
(CHCl3-Me2CO, 19:1), 650–735 (CHCl3-Me2CO, 9:1), 736–955 (CHCl3-Me2CO, 9:1). Sfrs 601–602 were
combined and crystalized in MeOH to give 10.5 mg of paecilin E (1). Frs 453–457 were combined
(1.49 g) and crystalized in MeOH to give 118 mg of secalonic acid A. The mother liquor was applied
on a column of Sephadex LH-20 (10 g) and eluted with a 1:1 mixture of MeOH-CH2Cl2, wherein
20 sfrs of 10 mL were collected. Sfrs 10–12 were combined (10.6 mg) and crystalized in MeOH to give
another 8.7 mg of helvoloic acid. Frs 617–623 were combined (39 mg) and applied on a column of
Sephadex LH-20 (10 g) and eluted with a 1:1 mixture of MeOH: CH2Cl2, wherein 30 sfrs of 3 mL were
collected. Sfrs 17–30 were combined and crystalized in MeOH to give 4.5 mg of fellutanine A [13]. Frs
631–675 were combined (3.61 g) and crystallized in MeOH to give further 68.3 mg of secalonic acid A.
The crude ethyl acetate extract of N. tsunodae KUFC 9213 was dissolved in 500 mL of CHCl3,
and then washed with H2O (3 × 500 mL). The organic layers were combined and dried with
anhydrous Na2SO4, filtered and evaporated under reduced pressure to give 60 g of the crude
chloroform extract, which was applied on a column of silica gel (410 g), and eluted with mixtures
of petrol-CHCl3, CHCl3-Me2CO and CHCl3-MeOH , wherein 250 mL fractions were collected as
follows: Frs 1–99 (petrol-CHCl3, 1:1), 100–201 (petrol-CHCl3, 3:7), 202–219 (petrol-CHCl3, 1:9),
220–349 (CHCl3-Me2CO, 9:1), 350–391 (CHCl3-Me2CO, 7:3), 392–437 (CHCl3-MeOH, 9:1), 438–455
(CHCl3-MeOH, 7:3) and 456–459 (MeOH). Frs 134–196 were combined (2.0 g) and purified by TLC
(Silica gel G254, CHCl3-petrol-HCO2H, 14:5:1) to give 40.5 mg of byssochlamic acid [7]. Frs 226–234 were
combined (4.0 g) and applied on a column of silica gel (33 g), and eluted with mixtures of petrol-CHCl3,
CHCl3, and CHCl3-Me2CO, wherein 100 mL subfractions (sfrs) were collected as follows: Sfrs
1–5 (petrol-CHCl3, 7:3), 6–18 (petrol-CHCl3, 3:2), 19–20 (petrol-CHCl3, 1:1), 21–34 (petrol-CHCl3,
3:7), 25–30 (petrol-CHCl3, 9:1), 31–42 (CHCl3) and 43–48 (CHCl3-Me2CO, 9:1). Sfrs 24–30 were
combined (211 mg) and crystallized in MeOH to give 64 mg of byssochlamic acid and 35 mg of
hopan-3β,22 diol [15]. Sfrs 31–42 were combined (174 mg) and crystallized in MeOH to give further
23.4 mg of byssochlamic acid. Frs 235–244 were combined (1.75 g) and applied on a column of silica
gel (45 g), and eluted with mixtures of petrol-CHCl3 and CHCl3, wherein 100 mL sfrs were collected
as follows: Sfrs 1–9 (petrol-CHCl3, 7:3), 20–32 (petrol-CHCl3, 3:2), 33–45 (petrol-CHCl3, 1:1), 46–60
(petrol-CHCl3, 3:7), 61–112 (petrol-CHCl3, 1:9) and 113–115 (CHCl3). Sfrs 1–5 were combined and
purified by TLC (Silica gel G254, CHCl3-Me2CO-HCO2H, 97:3:0.1) to give 4.6 mg of byssochlamic acid
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and 12.4 mg of chevalone C [16]. Sfrs 6–75 were combined (91 mg) and crystalized in MeOH to give
further 15 mg of byssochlamic acid. Sfrs 76–114 were combined (863 mg) and purified by TLC (Silica
gel G254, CHCl3-Me2CO-HCO2H, 97:3:0.1) to give an additional 15.7 mg of byssochlamic acid, 22.4 mg
of chevalone C and 39.3 mg of sartorypyrone B [5]. Frs 245–263 were combined (1.53 g) and applied
on a column of silica gel (45 g), and eluted with mixtures of petrol-CHCl3, CHCl3, CHCl3-Me2CO,
and Me2CO, wherein 100 mL sfrs were collected as follows: Sfrs 1–12 (petrol-CHCl3, 7:3), 13–20
(petrol-CHCl3, 3:2), 21–40 (petrol-CHCl3, 1:1), 41–50 (petrol-CHCl3, 2:3), 51–68 (petrol-CHCl3, 3:7),
69–85 (petrol-CHCl3, 1:4), 86–100 (petrol-CHCl3, 1:9), 101–122 (CHCl3), 123–148 (CHCl3-Me2CO, 9:1),
149–158 (Me2CO). Sfrs 23–123 were combined (57 mg) and crystalized in MeOH to give 12 mg of
byssochlamic acid and 7.1 mg of sartorypyrone B. Frs 264–312 were combined (1.12 g) and applied on
a column of silica gel (18 g), and eluted with mixtures of petrol-CHCl3 and CHCl3, wherein 100 mL sfrs
were collected as follows: Sfrs 1–17 (petrol-CHCl3, 7:3), 18–48 (petrol-CHCl3, 3:2), 49–72 (petrol-CHCl3,
1:1), 73–76 (petrol-CHCl3, 2:3), 77–90 (petrol-CHCl3, 3:7), 91–100 (petrol-CHCl3, 1:9), 116 (CHCl3). Sfrs
16–68 were combined (93 mg) and crystalized in MeOH to give 33 mg of byssochlamic acid. Sfrs
69–115 were combined (711 mg) and purified by TLC (Silica gel G254, CHCl3-Me2CO-HCO2H, 4:1:0.01)
to give to 14.1 mg of lumichrome [21] and 8.0 mg of helvolic acid [5]. Frs. 313–352 were combined
(487 mg) and applied on a Sephadex LH-20 column (10 g) and eluted with MeOH, wherein 20 mL
of 42 sfrs were collected. Sfrs 15–42 were combined (104 mg) and purified by TLC (Silica gel G254,
CHCl3-Me2CO-HCO2H, 4:1:0.01) to give 10 mg of byssochlamic acid, 7.8 mg of helvolic acid, 4.7 mg
of lumichrome, 10.6 mg of (3β,5α,22E)-3,5-dihydroxyergosta-7,22-dien-6-one (4) [28] and 21.6 mg of
chromanol (3). Fractions 400–420 were combined (1.47 g) and applied on a Sephadex LH-20 column
(20 g) and eluted with MeOH, wherein 20 mL of 42 sfrs were collected. Sfr 23–42 were combined
(306 mg) and purified by TLC (Silica gel G254, CHCl3-Me2CO-HCO2H, 9:1:0.01) to give to 25.4 mg of
byssochlamic acid and 5.3 mg of harmane [20]. Frs 421–440 were combined (1.33 g) and applied on
a Sephadex LH-20 column (20 g) and eluted with MeOH, wherein 20 mL of 33 sfrs were collected. Sfrs
18–33 were combined (126 mg) and crystalized in MeOH to give additional 42.2 mg of harmane.
3.3.1. Paecilin E (1)
White crystal; mp 203–204 ◦C. [α]20D +154 (c 0.03, MeOH); IR (KBr) υmax 3444, 2959, 2920, 1790,
1738, 1645, 1470, 1261cm−1. For 1H and 13C spectroscopic data (DMSO, 500 and 125 MHz), see Table 2;
(+)-HRESIMS m/z 639.1718 (M + H)+ (calcd. for C32H31O14, 639.1714).
3.3.2. Dankasterone (2)
White crystal; mp 135–137 ◦C. [α]20D +166 (c 0.04, CHCl3); IR (KBr) υmax 2959, 2924, 1727, 1710,
1536, 1462 cm−1. For 1H and 13C spectroscopic data (CDCl3, 500.13 and 125.8 MHz), see Table S1;
(+)-HRESIMS m/z 347.1111 (M + Na)+ (calcd. for C16H20O7 Na, 341.1107). (+)-HRESIMS m/z 425.3054
(M + H)+ (calcd. for C28H41O3, 425.3056).
3.3.3. (1R, 8S, 9R)-1,9-Dihydroxy-8-(2-hydroxypropan-2-yl)-4-methoxy-5-methyl-1,7,8,9-tetrahydro-3H-
furo[3,4-f]chromen-3-one (3)
White crystal; mp 223–224 ◦C. [α]20D –80 (c 0.05, CHCl3); IR (KBr) υmax 3467, 3434, 3018, 2969, 1743,
1597, 1507, 1262 cm−1. For 1H and 13C spectroscopic data (DMSO, 300.13 and 75.4 MHz), see Table 2;
(+)-HRESIMS m/z 347.1111 (M + Na)+ (calcd. for C16H20O7 Na, 341.1107).
3.3.4. (3β,5α,22E)-3,5-Dihydroxyergosta-7,22-dien-6-one (4)
White amorphous solid; [α]20D +60 (c 0.05, CHCl3); For
1H and 13C spectroscopic data
(CDCl3, 500.13 and 125.8 MHz), see Table S2. (+)-HRESIMS m/z 429.3388 (M + H)+ (calcd. for
C28H45O3, 429.3369).
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3.4. Electronic Circular Dichroism (ECD)
The ECD spectrum of 4 (1.6 mM in methanol) was obtained in a Jasco J-815 CD spectropolarimeter
with a 0.01 mm cuvette and eight accumulations. Dihedral driver and MMFF95 minimizations were
done in Chem3D Ultra (Perkin-Elmer Inc., Waltham, MA, USA). All DFT minimizations and ECD
spectral calculations (TD-DFT) were performed with Gaussian 09W (Gaussian Inc., Wallingford,
CT, USA) using the APFD/6-311+G (2d, p) method/basis set [32] with IEFPCM solvation model of
methanol. The simulated spectral lines (Figure 4) were obtained by summation of Gaussian curves,
as recommended in Stephens and Harada [33]. A line broadening of 0.4 eV was applied to all transitions
to generate the calculated spectral lines.
3.5. X-ray Crystal Structure of 1 and 3
Diffraction data were collected with a Gemini PX Ultra equipped with CuKα radiation
(λ = 1.54184 Å). The structures were solved by direct methods using SHELXS-97 and refined with
SHELXL-97 [34]. Carbon, oxygen and sulfur atoms were refined anisotropically. Hydrogen atoms
were either placed at their idealized positions using appropriate HFIX instructions in SHELXL, and
included in subsequent refinement cycles, or were directly found from difference Fourier maps and
were refined freely with isotropic displacement parameters. Full details of the data collection and
refinement and tables of atomic coordinates, bond lengths and angles, and torsion angles have been
deposited with the Cambridge Crystallographic Data Centre.
Paecilin E (1). Crystals were monoclinic, space group P21, cell volume 1487.9(2) Å3 and unit cell
dimensions a = 13.5112(7) Å, b = 8.1824(11) Å and c = 14.7531(9) Å and β = 114.179(7)◦ (uncertainties
in parentheses). The refinement converged to R (all data) = 5.27% and wR2 (all data) = 10.31%.
The absolute structure was established with confidence (flack x parameter 0.0(2)). Diffraction data
were collected at 148 K. CCDC 1579859.
(1R, 8S, 9R)-1,9-Dihydroxy-8-(2-hydroxypropan-2-yl)-4-methoxy-5-methyl-1,7,8,9-tetrahydro-3H-
furo[3,4-f]chromen-3-one (3). Crystals were triclinic, space group P1, cell volume 773.78(18) Å3 and unit
cell dimensions a = 9.1295(12) Å, b = 9.2537(14) Å and c = 10.4317(12) Å and angles α = 94.622(11)◦,
β = 104.310(11)◦ and γ = 112.486(13)◦ (uncertainties in parentheses). The refinement converged
to R (all data) = 14.12% and wR2 (all data) = 29.88%. Diffraction data were collected at 291 K.
CCDC 1579876.
3.6. Antibacterial Activity Bioassays
3.6.1. Bacterial Strains and Growth Conditions
For reference, a clinical isolate sensitive to the most commonly used antibiotic families, and four
multidrug-resistant bacterial strains were used in this study. The Gram-positive bacteria comprised
Staphylococcus aureus ATCC 29213, Enterococcus faecalis ATCC 29212, a clinical isolate S. aureus 40/61/24,
MRSA S. aureus 66/1 isolated from public buses [35], and VRE E. faecalis A5/102 and VRE E. faecalis
B3/101 isolated from river water [36]. The Gram-negative bacteria used were Escherichia coli ATCC
25922, Pseudomonas aeruginosa ATCC 27853, and a clinical isolate ESBL E. coli SA/2. Frozen stocks
of all strains were grown in Mueller-Hinton agar (MH-BioKar diagnostics, Allone, France) at 37 ◦C.
All bacterial strains were sub-cultured in MH agar and incubated overnight at 37 ◦C before each assay.
3.6.2. Antimicrobial Susceptibility Testing
The minimum inhibitory concentration (MIC), which was used for determining the antibacterial
activity of each compound, was determined according to the method described previously by May
Zin et al. [37].
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3.6.3. Biofilm Formation Inhibition Assay
The effect of the compounds on biofilm formation was assessed using crystal violet staining as
previously described by May Zin et al. [37].
3.6.4. Antibiotic Synergy Testing
Evaluation of the combined effect of the compounds and clinical relevant antimicrobial drugs
was performed according to the method previously described by May Zin et al. [37].
4. Conclusions
Chemical investigation of the culture of the marine-derived fungus Neosartorya fennelliae KUFA 0811,
isolated from the marine sponge Clathria reinwardtii, resulted in the isolation of the previously undescribed
6-8 dimer of substituted 3,5-dihydrochromone which we have named paecilin E (1), and the previously
reported metabolites including β-sitostenone, ergosta-4,6,8 (14), 22-tetraen-3-one, cyathisterone,
byssochlamic acid, dehydromevalonic acid lactone, chevalone B, aszonalenin, dankasterone A (2),
helvolic acid, secalonic acid A and fellutanine A. Re-examination of the culture of N. tsunodae KUFC 9213,
led to the isolation of the chromanol derivative (3), in addition to sartorypyrone B and helvolic which
were previously isolated from this fungus, and other known compounds including byssochlamic acid,
hopan-3β,22-diol (5), chevalone C, (3β,5α,22E)-3,5-dihydroxyergosta-7,22-dien-6-one (4), the alkaloid
harmane (7) and lumichrome (6). The absolute configurations of the stereogenic carbons of the previously
undescribed paecilin E (1) and the chromanol derivative (3) were unambiguously established by X-ray
analysis. Although (3β,5α,22E)-3,5-dihydroxyergosta-7,22-dien-6-one (4) has been reported from several
sources, the absolute configuration of its C-5 had never been determined unambiguously by any modern
techniques. By comparison of the experimental and calculated ECD spectra, we determined conclusively
the absolute configuration of C-5 as 5R. Paecilin E (1), dankasterone A (2), the chromanol derivative (3)
and some of the isolated compounds which have not been previously tested for antibacterial activity, i.e.,
(3β,5α,22E)-3,5-dihydroxyergosta-7,22-dien-6-one (4), hopan-3β,22-diol (5), lumichrome (6) and harmane
(7) were tested for their antibacterial activity against Gram-positive and Gram-negative bacteria of four
reference strains, a clinical isolate sensitive to the most commonly used antibiotic families, and four
multidrug-resistant isolates from the environment. Only paecilin E (1) and dankasterone A (2) were able
to inhibit growth of Gram-positive bacteria. While paecilin E (1) exhibited an inhibitory effect on both S.
aureus ATCC 29213 and E. faecalis ATCC 29212 with MIC values of 32 µg/mL and 16 µg/mL, respectively,
dankasterone (2) was only effective against E. faecalis ATCC 29212 and VRE E. faecalis A5/102, with
MIC of 32 µg/mL and 64 µg/mL, respectively. Despite a great structural diversity of the secondary
metabolites produced by these two marine-derived species of Neosartorya, a majority of them did not
possess the antibacterial activity. Nevertheless, it does not mean that they do not have other interesting
biological activities. Therefore, more biological assays will be performed in the future.
Supplementary Materials: The following are available online at www.mdpi.com/1660-3397/15/12/375/s1,
Figure S1: Structures of metabolites isolated from Neosartorya tsunodae KUFC 9231 and N. fennelliae KUFA 0811,
Figures S2–S48: 1D and 2D NMR spectra of isolated compounds, Figure S49: Ortep view of dankasterone A (2),
Table S1: 1H and 13C NMR (CDCl3, 500 MHz and 125 MHz) and HMBC assignment for 2, Table S2: 1H and 13C
NMR (CDCl3, 500 MHz and 125 MHz) of 4.
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